The minimal inhibitory concentration for sulbactam was not associated with the outcome of infections caused by carbapenem-resistant Acinetobacter sp. treated with ampicillin/sulbactam. Clinics. 2013;68(4):569-573. doi:10.1590/clin.v68i4.76804